Vera Therapeutics (VERA) Depreciation & Amortization (CF) (2020 - 2026)
Vera Therapeutics posted quarterly Depreciation & Amortization (CF) of $140000.0 for Q1 2026, up 64.71% year-on-year from $85000.0 in Q1 2025, and up 3.7% on a QoQ basis from $135000.0 in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $140000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 64.71% year-over-year to $140000.0; the trailing twelve-month figure through Mar 2026 stood at $523000.0 (up 192.18% YoY), and the FY2025 full-year result was $468000.0, up 345.71% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $140000.0, up from $135000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $517000.0 in Q2 2023 and bottomed at -$597000.0 in Q4 2022.
- The 5-year median for Depreciation & Amortization (CF) is $15000.0 (2024), against an average of -$6588.2.
- The widest annual swing landed in 2023, when Depreciation & Amortization (CF) slumped 5722.22%; it then jumped 1275.0% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at -$597000.0 in 2022, then surged by 100.67% to $4000.0 in 2023, then surged by 1275.0% to $55000.0 in 2024, then jumped by 145.45% to $135000.0 in 2025, then climbed by 3.7% to $140000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $140000.0 (Q1 2026), $135000.0 (Q4 2025), and $129000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | 140,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140,000.00 |
| Mar 31, 2026 | 140,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 517,000.00 |
| Jun 30, 2023 | 517,000.00 |
| Mar 31, 2023 | -506,000.00 |
| Mar 31, 2023 | -506,000.00 |
| Dec 31, 2022 | -597,000.00 |
| Dec 31, 2022 | -597,000.00 |
| Sep 30, 2022 | -152,000.00 |
| Sep 30, 2022 | -152,000.00 |
| Jun 30, 2022 | -106,000.00 |
| Jun 30, 2022 | -106,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | 59,000.00 |
| Sep 30, 2021 | 59,000.00 |
| Jun 30, 2021 | 50,000.00 |
| Jun 30, 2021 | 50,000.00 |
| Mar 31, 2021 | 35,000.00 |
| Mar 31, 2021 | 35,000.00 |
| Dec 31, 2020 | -642,000.00 |
| Dec 31, 2020 | -642,000.00 |
| Sep 30, 2020 | 673,000.00 |
| Sep 30, 2020 | 673,000.00 |
| Jun 30, 2020 | 112,000.00 |
| Jun 30, 2020 | 112,000.00 |
| Mar 31, 2020 | 108,000.00 |
| Mar 31, 2020 | 108,000.00 |